AI assistant
REPLIGEN CORP — Director's Dealing 2013
Mar 27, 2013
30826_dirs_2013-03-27_7ff38114-3801-4e0d-a411-f1e8d95b52f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2013-03-22
Reporting Person: Benjamin Howard (VP Business Development)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $4.25 | 2019-02-11 | Common Stock (100000) | Direct | |
| Stock Option (Right to Buy) | $3.33 | 2020-07-15 | Common Stock (25000) | Direct | |
| Stock Option (Right to Buy) | $6.23 | 2023-02-28 | Common Stock (40000) | Direct |
Footnotes
F1: 100,000 options were granted on 02/11/2009. 20,000 options vested on each of the following dates: 02/11/2010, 02/11/2011, 02/11/2012 and 02/11/2013. 20,000 options will vest on 02/11/2014.
F2: 25,000 options were granted on 07/15/2010. 5,000 options vested on each of the following dates: 07/15/2011 and 07/15/2012. 5,000 options will vest on each of the following dates: 07/15/2013, 07/15/2014 and 07/15/2015.
F3: 40,000 options were granted on 02/28/2013. 10,000 options will vest on each of the following dates: 02/28/2014, 02/28/2015, 02/28/2016 and 02/28/2017.